Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545413 | SCV000644274 | benign | Tuberous sclerosis 2 | 2023-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001012884 | SCV001173398 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-01 | criteria provided, single submitter | clinical testing | The p.T577I variant (also known as c.1730C>T), located in coding exon 16 of the TSC2 gene, results from a C to T substitution at nucleotide position 1730. The threonine at codon 577 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000545413 | SCV002040633 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004722897 | SCV005332898 | uncertain significance | not provided | 2023-07-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Myriad Genetics, |
RCV000545413 | SCV005406104 | likely benign | Tuberous sclerosis 2 | 2024-08-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |